PostEra
Medicinal Chemistry powered by Machine Learning
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot. PostEra is a Y Combinator company (Winter 2020). YC-listed status: Active.
- Website
- postera.ai
- Location
- Boston, MA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Proton — AI platform for medicinal chemistry used to discover and develop small-molecule medicines for biopharma partners. · Saas · Enterprise
Links
- Y Combinator profileycombinator